Collegium Pharmaceutical (COLL) Q4 2024 Earnings Report

511 Followers

COLL Q4 2024 EPS Results

Actual EPS$1.77

Consensus EPS$1.54

Beat/MissBeat by +$0.23

One Year Ago EPS$1.58

Actual Revenue$181.95M

Expected Revenue$179.75M

Beat/MissBeat by +$2.20M

YoY Revenue Growth+21.51%

QuarterQ4 2024

Date02/27/2025

TimeAfter Close

Conference CallThursday, February 27, 2025

COLL Upcoming Earnings

Collegium Pharmaceutical's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

COLL Q4 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	1.86 / -	2.25	―
Aug 06, 2026	2026 (Q2)	1.72 / 1.92	1.68	14.29% (+0.24)
May 07, 2026	2026 (Q1)	1.52 / 1.76	1.49	18.12% (+0.27)
Feb 26, 2026	2025 (Q4)	2.14 / 2.04	1.77	15.25% (+0.27)
Nov 06, 2025	2025 (Q3)	1.86 / 2.25	1.61	39.75% (+0.64)
Aug 07, 2025	2025 (Q2)	1.62 / 1.68	1.62	3.70% (+0.06)
May 08, 2025	2025 (Q1)	1.43 / 1.49	1.45	2.76% (+0.04)
Feb 27, 2025	2024 (Q4)	1.54 / 1.77	1.58	12.03% (+0.19)
Nov 07, 2024	2024 (Q3)	1.59 / 1.61	1.34	20.15% (+0.27)
Aug 08, 2024	2024 (Q2)	1.49 / 1.62	1.26	28.57% (+0.36)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed